Early stages of hypertensive encephalopathy development and modern potential of cerebro-protective therapy
Abstract
Aim. To study structural cerebral changes in patients with arterial hypertension (AH), taking into consideration 24-hour blood pressure monitoring (BPM) results and their dynamics during antihypertensive therapy.
Material and methods. In total, 212 AH patients aged 40-60 years (mean age 48,3±5,7 years) were examined. Cerebral magnetic resonance tomography, cerebral emission computed tomography, and 246hour BPM were performed. The therapy included enalapril (5-20 mg/d; n=32) and indapamide retard (1,5 mg/d; n=32) for 24 weeks.
Results. Structural cerebral changes, observed in 89,5% of AH patients, were significantly associated with 24-hour BPM parameters. Indapamide and enalapril therapy was associated with significant BP reduction, according to 24-hour BPM data, as well as with cerebral perfusion improvement (primarily in occipital region) and decreased disturbances of liquor circulation and periventricular edema. The parameters studied improved to a greater extent in the indapamide group.
Conclusion. Circadian BP profile normalization, during indapamide retard therapy, was associated with improved cerebral perfusion and structure. Positive dynamics of cerebral parameters was manifested to a lesser extent in the enalapril group.
About the Authors
M. F. MordovinRussian Federation
G. V. Semke
Russian Federation
M. V. Kolodina
Russian Federation
References
1. Верещагин Н.В., Варакин Ю.Я. Регистры инсульта в России: результаты и методологическик аспекты проблемы. Инсульт 2001; 1: 34-40.
2. Lazzarino L, Nicolai A, Valassi F. Leukoaraiosis: correlation of arterial hypertension and lacunar infarct (study of 80 patients). Schweiz Arch Neurol Psychiatr 1990; 141(4): 345-9.
3. Hougaku U, Matsumoto M, Kitagawa K, et al. Silent cerebral infarction as a form of hypertensive target organ damage in the brain. Hypertension 1992; 20(6): 816-20.
4. Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28(10): 1932-9.
5. Афанасьева Н.Л., Мордовин В.Ф., Ефимова Н.Ю. и др. Гипотензивная эффективность и церебропротективное влияние бета-блокатора метопролола. РКЖ 2005; 1: 60-4.
6. Белокопытова Н.В., Мордовин В.Ф., Рипп Т.М. Исследование гипотензивной эффективности индапа и его влияние на структурно-функциональные изменения сердца и ауторегуляцию тонуса периферических артерий. РКЖ 2004; 2: 60-3.
Review
For citations:
Mordovin M.F., Semke G.V., Kolodina M.V. Early stages of hypertensive encephalopathy development and modern potential of cerebro-protective therapy. Cardiovascular Therapy and Prevention. 2008;7(1):87-91. (In Russ.)